Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AMARIN CORP PLC\UK | 171,027 | reported | 10 Jan 2023 | tx 7+482,996−22,027 |
| GILEAD SCIENCES, INC. | 102,060 | reported | 06 May 2021 | tx 64+245,692−126,177 |
| MERCK & CO INC | 98,000 | reported | 03 Mar 2006 | tx 10+268,782−189,898 |
| SFBC INTERNATIONAL INC | 0 | reported | 20 Mar 2009 | tx 7+16,609−19,998 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jan 2023 | EXERCISE | AMARIN CORP PLC\UK | 22,027 | — | |
| 10 Jan 2023 | EXERCISE | AMARIN CORP PLC\UK | 22,027 | 0.00 USD | deriv |
| 27 Jun 2022 | GRANT_AWARD | AMARIN CORP PLC\UK | 98,959 | 0.00 USD | deriv |
| 27 Jun 2022 | GRANT_AWARD | AMARIN CORP PLC\UK | 122,359 | 0.00 USD | deriv |
| 13 Jun 2022 | PURCHASE | AMARIN CORP PLC\UK | 55,000 | 1.69 USD | first after silence |
| 10 Jan 2022 | GRANT_AWARD | AMARIN CORP PLC\UK | 81,082 | 0.00 USD | deriv |
| 10 Jan 2022 | GRANT_AWARD | AMARIN CORP PLC\UK | 103,569 | 0.00 USD | deriv |
| 06 May 2021 | EXERCISE | GILEAD SCIENCES, INC. | 1,936 | — | |
| 06 May 2021 | EXERCISE | GILEAD SCIENCES, INC. | 1,936 | — | deriv |
| 05 May 2020 | EXERCISE | GILEAD SCIENCES, INC. | 2,270 | — | |
| 06 May 2020 | GRANT_AWARD | GILEAD SCIENCES, INC. | 1,936 | — | deriv |
| 06 May 2020 | GRANT_AWARD | GILEAD SCIENCES, INC. | 7,886 | 0.00 USD | deriv |
| 05 May 2020 | EXERCISE | GILEAD SCIENCES, INC. | 2,270 | — | deriv |
| 07 Feb 2020 | EXERCISE | GILEAD SCIENCES, INC. | 20,282 | 20.65 USD | |
| 07 Feb 2020 | SALE | GILEAD SCIENCES, INC. | 20,282 | 69.00 USD | |
| 06 Feb 2020 | SALE | GILEAD SCIENCES, INC. | 21,720 | 68.12 USD | |
| 06 Feb 2020 | EXERCISE | GILEAD SCIENCES, INC. | 21,720 | 19.63 USD | |
| 06 Feb 2020 | EXERCISE | GILEAD SCIENCES, INC. | 21,720 | 0.00 USD | deriv |
| 07 Feb 2020 | EXERCISE | GILEAD SCIENCES, INC. | 20,282 | 0.00 USD | deriv |
| 28 Aug 2019 | EXERCISE | GILEAD SCIENCES, INC. | 4,908 | 23.76 USD | |
| 28 Aug 2019 | SALE | GILEAD SCIENCES, INC. | 4,908 | 63.91 USD | |
| 28 Aug 2019 | EXERCISE | GILEAD SCIENCES, INC. | 4,908 | 0.00 USD | deriv |
| 08 May 2019 | GRANT_AWARD | GILEAD SCIENCES, INC. | 2,270 | — | deriv |
| 08 May 2019 | GRANT_AWARD | GILEAD SCIENCES, INC. | 11,848 | 0.00 USD | deriv |
| 07 May 2019 | EXERCISE | GILEAD SCIENCES, INC. | 2,283 | — |
5 purchases reported after at least 12 months of silence — most recent on 13 Jun 2022.